Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
Completed · Not applicable
Conditions studied: Prostate Cancer
In brief
This is a pilot evaluation of a patient-centered intervention that enables providers to support men on active surveillance to maximize adherence. Conducted in urology practices, this pilot will measure key patient-reported, provider-reported, and implementation outcomes. Successful completion of this work will inform a subsequent multi-center effectiveness-implementation hybrid design trial and ultimately will improve low-risk cancer management by effectively engaging Primary Care Physicians (PCPs) in care delivery.
Key facts
- Study ID
- NCT05764005
- Run by
- University of Michigan Rogel Cancer Center
- People needed
- 39
- Starts
- 2022-11-09
- Expected to finish
- 2024-03-11
- Last updated by the study team
- 2026-03-06
Who can join
Age: 55 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- University of Michigan Rogel Cancer Center — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.